Ann: MOU with ICL for global distribution of Alexiflam NF, page-33

The MOU establishes a framework for the potential commercialization of Alexiflam NF with ICL, including:• Alexium retaining rights to sell Alexiflam NF into defined markets currently under development by Alexium.• ICL being granted sole global marketing and sales rights for the Alexium NF product, the terms of which are subject to thefinal agreement.• Both parties collaborating to assess the costs and address the practical details involved with the volume production ofAlexiflam NF.

So Inpatient Tomatoes

Volume production of Alexflam NF ( Operative word being being VOLUME ! )